
To assess the benefit of zzso zzso zzso within a weight management zzso 

Prospective zzso controlled trial in a health maintenance zzso 

zzso patients zzso zzso zzso starting a weight management program were zzso Patients were randomly assigned to participate in the program alone or to participate in the program and receive zzso for 12 zzso zzso measures were change in weight, body mass index zzso percentage body fat, serum zzso serum zzso and blood zzso 

At zzso there was a younger age and higher weight, zzso and waist circumference in the drug zzso There was more degenerative joint disease in the zzso zzso The mean weight loss at 6 months was zzso zzso zzso confidence zzso zzso zzso to zzso zzso in the drug group vs zzso zzso zzso zzso zzso to zzso zzso zzso zzso in the zzso zzso Weight loss was maintained at 12 zzso zzso reductions in zzso body fat, and waist circumference occurred in the drug zzso There were no significant changes in laboratory values or blood zzso Patients taking zzso experienced a significant increase in heart rate zzso zzso zzso zzso zzso zzso vs zzso zzso zzso zzso zzso to zzso zzso P zzso 

In this managed care setting, the effectiveness and safety of zzso were similar to those observed in randomized, zzso clinical efficacy zzso 

